Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × talactoferrin alfa × Clear all

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 513 Radiotherapy 374 Cyclophosphamide 363 Carboplatin 353 Capecitabine 338 Paclitaxel 330 Oxaliplatin 329 Docetaxel 313 Gemcitabine 311 Fluorouracil 286 Drug Therapy 264 apatinib 246 Bevacizumab 242 camrelizumab 217 Etoposide 199 Irinotecan 181 Doxorubicin 180 Dexamethasone 159 Leucovorin 158 pembrolizumab 150 Cytarabine 141 sintilimab 140 Blood Specimen Collection 140 anlotinib 139 Neoadjuvant Therapy 139 Pemetrexed 136 toripalimab 126 Surgical Procedures, Operative 125 Radiosurgery 125 S 1 (combination) 124

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00706862 2012-03-15

FORTIS-C

Agennix

Phase 3 Unknown

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡